NCT00168155: Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma |
|
|
| Completed | 2 | 70 | Canada | perioperative chemotherapy | Alberta Health services, Pfizer | Colorectal Adenocarcinoma, Liver Metastases | 05/09 | 05/09 | | |
| Completed | 2 | 22 | Europe | sunitinib added to FOLFIRI, Sutent | Central European Society for Anticancer Drug Research | Metastatic Colorectal Cancer, Liver Metastases | 07/10 | 09/11 | | |
| Withdrawn | 2 | 0 | Europe | Bevacizumab, VEGF antibody | University of Regensburg, University of Halle Medical Faculty | Colon Cancer Liver Metastasis | 05/13 | 05/13 | | |
NCT01320683: Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer |
|
|
| Terminated | 2 | 1 | US | oxaliplatin, 1-OHP, Dacotin, Dacplat, Eloxatin, L-OHP, leucovorin calcium, CF, CFR, LV, fluorouracil, 5-fluorouracil, 5-Fluracil, 5-FU, bevacizumab, anti-VEGF humanized monoclonal antibody, anti-VEGF monoclonal antibody, Avastin, rhuMAb VEGF, yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A, laboratory biomarker analysis, pharmacological study, pharmacological studies, irinotecan hydrochloride, Campto, Camptosar, CPT-11, irinotecan, U-101440E | City of Hope Medical Center, National Cancer Institute (NCI) | Liver Metastases, Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer | 12/14 | 12/14 | | |
